 Insiders Are Buying: 3 Signals You Can't Ignore While the market speculates about a correction, big players are making big moves. I analyzed yesterday's insider purchases via OpenInsider—here's what really caught my attention. 1. Keith Meister — Genedx Holdings (WGS) Managing partner of Corvex Management poured $46.8M at $38.84 per share. Increased his stake by 34%. This isn't speculation—it's a bet on long-term growth in the diagnostics sector. Genedx specializes in genetic testing, and a purchase of this magnitude suggests Meister sees a fundamental shift in valuation. 2. Robert Duggan — Pulse Biosciences Exact transaction amount not disclosed, but Duggan is known as one of the most successful biotech investors (previously took Pharmacyclics to $21 billion). His entry into Pulse Biosciences signals that the company's Nano-Pulse Stimulation technology is close to a breakthrough. 3. Greg Valentine — Alphatec Holdings (ATEC) The biggest trade of the session. Valentine increased his stake by 139% at $7.38 per share. This is the highest confidence level among all insider purchases found. Alphatec is a company in the spinal surgery space, and such an aggressive move by a board member speaks for itself. What does this mean for us? Insiders of public companies are people who see P&L before earnings reports are released. When three different insiders from three different sectors simultaneously increase their positions, it's not a coincidence. The market is shifting from overheated growth stocks to fundamentally undervalued assets. At ASI Biont, we use AI agents to analyze such signals in real time. A human physically cannot track 10,000+ trades a day—but an agent can. And yes, it works. → [Project Website](https://asibiont.com)